Skip to main content
. 2013 Dec 15;35(4):2871–2882. doi: 10.1007/s13277-013-1511-7

Table 2.

Up-regulated expression of LOX in tumor tissues

Cancer type Results Function References
Breast cancer

10-year DMSFa low

10-year OSb low

Activate HIF1-Akt pathway; mediate hypoxic control of metastasis; regulate actin filament formation; contribute to mechanotransduction-mediated regulation of TGF-β signaling; recruit BMDCs to form the pre-metastatic niche [29, 34, 36]
Colorectal cancer / Correlated with absence of lymphovascular invasion; activate PI3K–Akt pathway to up-regulate HIF-1α protein synthesis [37, 38]
Head and neck squamous cell carcinoma 5-year OSc low Strongly associated with increased metastasis, progression and death [39]
Lung adenocarcinoma 5-year OS low ECM remodeling; associated with advanced stage and metastasis [40, 41]
Oral and oropharyngeal squamous cell carcinoma 10-year OS low Independent prognostic biomarker and predictor of lymph node metastasis [42]

a10-year DMSF: 10-year distant metastasis free survival

b10-year OS low: 10-year overall survival

c5-year OS low: 5-year overall survival